Analyst Ratings for MedAssets (MDAS)
MDAS Rating Summary
MDAS Price Target Summary
- Highest: $19.00 (UBS)
- Lowest: $13.00 (Sterne Agee)
- Average: $15.25
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$15.25 (-16.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/2/2012 | Raymond James | Upgrade | Strong Buy (Market Perform) |
N/A (N/A) |
12.85 | 18.21 | 41.71% | Details |
| 7/12/2012 | ISI Group | New Coverage | Buy (N/A) |
15.50 (N/A) |
13.52 | 18.21 | 34.69% | Details |
| 6/28/2012 | Cowen | Upgrade | Outperform (Neutral) |
N/A (N/A) |
12.93 | 18.21 | 40.84% | Details |
| 6/21/2012 | UBS » Updated 8/2/2012 |
Upgrade | Buy (Neutral) |
19.00 (18.00) |
12.72 | 18.21 | 43.16% | Details |
| 5/23/2012 | Lazard Capital | New Coverage | Buy (N/A) |
17.00 (N/A) |
11.39 | 18.21 | 59.88% | Details |
| 2/27/2012 | Caris & Co. | Downgrade | Average (N/A) |
14.00 (N/A) |
14.10 | 18.21 | 29.15% | Details |
| 1/24/2012 | Sterne Agee | New Coverage | Buy (N/A) |
13.00 (N/A) |
10.66 | 18.21 | 70.83% | Details |
| 7/15/2011 | Goldman Sachs | New Coverage | Neutral (N/A) |
N/A (N/A) |
13.19 | 18.21 | 38.06% | Details |
| 7/8/2011 | Baird | Upgrade | Outperform (N/A) |
N/A (N/A) |
13.36 | 18.21 | 36.3% | Details |
| 6/9/2011 | Leerink Swann | Downgrade | Market Perform (N/A) |
N/A (N/A) |
13.61 | 18.21 | 33.8% | Details |
| 4/26/2011 | Oppenheimer | New Coverage | Outperform (N/A) |
N/A (N/A) |
15.64 | 18.21 | 16.43% | Details |
| 3/18/2011 | Madison Williams | Upgrade | Buy (N/A) |
N/A (N/A) |
14.89 | 18.21 | 22.3% | Details |
| 2/25/2011 | Avondale Partners | Downgrade | Market Perform (N/A) |
N/A (N/A) |
14.96 | 18.21 | 21.72% | Details |
| 2/25/2011 | William Blair | Downgrade | Market Perform (N/A) |
N/A (N/A) |
15.40 | 18.21 | 18.25% | Details |
| 2/25/2011 | Stifel Nicolaus | Downgrade | Hold (N/A) |
N/A (N/A) |
15.40 | 18.21 | 18.25% | Details |
